Mereo BioPharma Group has announced that Dr. Denise Scots-Knight, chief executive officer of Mereo, has been appointed as a member of the Board of Directors at Elanco Animal Health

Mereo is a biopharmaceutical company focused on the development and commercialisation of innovative therapeutics that aim to improve outcomes for patients with rare diseases.

The appointment will be effective from 11 March 2019.